Latest Insights on REGN
High-Quality Pharma Stock Captures Powerful Biotech Mega Trend
May 3, 2022 Money & Markets Daily
Among the most lucrative mega trends of the next decade, biotech is poised to grow revenues 77% by 2026. This Power Stock has been on the front lines of the battle against COVID-19 and rates a 96 on our proprietary system. Be a Biotech Value Investor (Start With 2 Stocks!)
February 21, 2022 Investing
Do you want to be a biotech value investor? It's possible to target solid companies trading at cheaper valuations in tech sectors. 2 Stocks Set for Massive Post-Earnings Moves (FISV & EXPE Analysis)
February 6, 2022 Investing
In this week's Earnings Edge: Fiserv Inc. (Nasdaq: FISV) and Expedia Group Inc. (Nasdaq: EXPE) could head in different directions post-call. SIRI, REGN Earnings: A Prime Candidate for Options Straddle
January 30, 2022 Investing
Regeneron Pharmaceuticals (Nasdaq: REGN) and Sirius XM Holdings (Nasdaq: SIRI) stocks are set to break out. Keep an eye on earnings. Weber IPO: What to Expect From the Backyard BBQ King
July 31, 2021 Markets
Here's a preview of the Weber Inc. IPO, and deep dive into General Motors' earnings expecations.